Compare ICU & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICU | CCM |
|---|---|---|
| Founded | 2018 | 1997 |
| Country | United States | China |
| Employees | 17 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.1M | 19.0M |
| IPO Year | N/A | 2009 |
| Metric | ICU | CCM |
|---|---|---|
| Price | $3.18 | $4.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 78.4K | 50.4K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $53.00 | N/A |
| Revenue Next Year | $50.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.22 | $3.18 |
| 52 Week High | $5.38 | $6.98 |
| Indicator | ICU | CCM |
|---|---|---|
| Relative Strength Index (RSI) | 32.11 | 48.85 |
| Support Level | $2.26 | $4.41 |
| Resistance Level | $4.96 | $5.27 |
| Average True Range (ATR) | 0.31 | 0.39 |
| MACD | -0.16 | 0.03 |
| Stochastic Oscillator | 0.00 | 33.33 |
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Geographically, the company derives revenue from PRC.